Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
KMT chair donates NT$1 million to Kumamoto earthquake relief
07/31/2026 05:53 PM - Business
U.S. dollar closes sharply lower on Taipei forex market
07/31/2026 05:41 PM - Science & Tech
Hon Hai subsidiary begins commercial operations of 5MW AI cluster
07/31/2026 05:25 PM - Society
Maserati driver, passenger who beat man into a coma lose appeals
07/31/2026 05:05 PM - Business
Taiwan's manufacturing sector continued to grow in June
07/31/2026 04:40 PM